enoxacin has been researched along with Neoplasms in 8 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Excerpt | Relevance | Reference |
---|---|---|
"The global pandemic of drug-sensitive cancers and the increasing threat from drug-resistant cancers make an urgent need to develop more effective anti-cancer candidates." | 2.61 | Quinolone hybrids and their anti-cancer activities: An overview. ( Gao, F; Wang, T; Xiao, J; Zhang, X, 2019) |
"Fleroxacin was also active against group JK-diphtheroids and Bacillus cereus." | 1.27 | In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients. ( Bodey, GP; Ho, DH; LeBlanc, B; Rolston, K, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Azéma, J | 1 |
Guidetti, B | 1 |
Dewelle, J | 1 |
Le Calve, B | 1 |
Mijatovic, T | 1 |
Korolyov, A | 1 |
Vaysse, J | 1 |
Malet-Martino, M | 1 |
Martino, R | 1 |
Kiss, R | 1 |
Lin, R | 1 |
Elf, S | 1 |
Shan, C | 1 |
Kang, HB | 1 |
Ji, Q | 1 |
Zhou, L | 1 |
Hitosugi, T | 1 |
Zhang, L | 1 |
Zhang, S | 1 |
Seo, JH | 1 |
Xie, J | 1 |
Tucker, M | 1 |
Gu, TL | 1 |
Sudderth, J | 1 |
Jiang, L | 1 |
Mitsche, M | 1 |
DeBerardinis, RJ | 1 |
Wu, S | 1 |
Li, Y | 1 |
Mao, H | 1 |
Chen, PR | 1 |
Wang, D | 1 |
Chen, GZ | 1 |
Hurwitz, SJ | 1 |
Lonial, S | 1 |
Arellano, ML | 1 |
Khoury, HJ | 1 |
Khuri, FR | 1 |
Lee, BH | 1 |
Lei, Q | 1 |
Brat, DJ | 1 |
Ye, K | 1 |
Boggon, TJ | 1 |
He, C | 1 |
Kang, S | 1 |
Fan, J | 1 |
Chen, J | 1 |
Gao, F | 1 |
Zhang, X | 1 |
Wang, T | 1 |
Xiao, J | 1 |
Felicetti, T | 1 |
Manfroni, G | 1 |
Melo, S | 1 |
Villanueva, A | 1 |
Moutinho, C | 1 |
Davalos, V | 1 |
Spizzo, R | 1 |
Ivan, C | 1 |
Rossi, S | 1 |
Setien, F | 1 |
Casanovas, O | 1 |
Simo-Riudalbas, L | 1 |
Carmona, J | 1 |
Carrere, J | 1 |
Vidal, A | 1 |
Aytes, A | 1 |
Puertas, S | 1 |
Ropero, S | 1 |
Kalluri, R | 1 |
Croce, CM | 1 |
Calin, GA | 1 |
Esteller, M | 1 |
Toro, EJ | 1 |
Ostrov, DA | 1 |
Wronski, TJ | 1 |
Holliday, LS | 1 |
Rolston, K | 1 |
Ho, DH | 2 |
LeBlanc, B | 2 |
Bodey, GP | 2 |
Rolston, KV | 1 |
3 reviews available for enoxacin and Neoplasms
Article | Year |
---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
Quinolone hybrids and their anti-cancer activities: An overview.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Quinolones; Structure-Activity Relationship | 2019 |
Rational identification of enoxacin as a novel V-ATPase-directed osteoclast inhibitor.
Topics: Actin Cytoskeleton; Animals; Anti-Infective Agents; Antineoplastic Agents; Candida; Candidiasis; Dru | 2012 |
5 other studies available for enoxacin and Neoplasms
Article | Year |
---|---|
7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Humans; Maximum | 2009 |
Targeting miRNA dysregulation with small molecules: the case of enoxacin.
Topics: Drug Discovery; Enoxacin; Humans; MicroRNAs; Neoplasms; RNA Interference | 2021 |
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Eno | 2011 |
In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria | 1988 |
In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negativ | 1987 |